MRI-guided BT: EMBRACE trial (1)
European study on MRI-guided brachytherapy in locally advanced
cervical cancer (GEC-ESTRO) started in 2008.
Prospective multicenter setting
Primary endpoints: LC and morbidity.
Secondary endpoints: RC, DFS, OS and QoL.
Correlation between image based DVH and outcome.
FIGO IB to IVA
EBRT + BT